Samdi Tech: Charles River Laboratories Acquires SAMDI Tech
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has acquired SAMDI Tech, Inc , a leading provider of high-quality, label-free high-throughput screening (HTS) solutions for drug discovery research.
Read full article »
CEO
Samdi Tech is an Illinois-based CRO that offers solutions such as drug discovery, screening, and assay development for sectors including biotech and pharmaceutical.
Read more